Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Clinical trial NCT04282044 · RECRUITING

Trial details

NCT number: NCT04282044
Sponsor: BioEclipse Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult Triple Negative Breast Cancer Colorectal Cancer Hepatocellular Carcinoma Osteosarcoma Epithelial Ovarian Cancer Gastric Cancer Non-small Cell Lung Cancer Malignant Melanoma

Start date: 2021-01-08
Primary completion: 2025-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.